Avecia
From Wikipedia, the free encyclopedia
Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production.[1] Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH.[1]
FormerlyAvecia Biotechnology Inc. (2001–2012)
TypeSubsidiary
IndustryBiotechnology
Defunct15 September 2015 
| Formerly | Avecia Biotechnology Inc. (2001–2012) |
|---|---|
| Type | Subsidiary |
| Industry | Biotechnology |
| Defunct | 15 September 2015 |
| Headquarters | Milford, Massachusetts, U.S. |
| Parent | Nitto Denko Corporation |
In 2009, Avecia Biologics Limited based in Billingham, UK was acquired by Merck and was later part of Fujifilm Diosynth Biotechnologies.[2]
In 2016, Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals.[3] Avecia was organized with a biologics business line and the oligonucleotide business line.